Related Experiment Video
Updated: Jun 3, 2025
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Targeting Mitochondria in Glioma: New Hopes for a Cure
Lidia Gatto1, Vincenzo Di Nunno1, Anna Ghelardini2
1Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
Abstract:
Drugs targeting mitochondrial energy metabolism are emerging as promising antitumor therapeutics. Glioma treatment is extremely challenging due to the high complexity of the tumor and the high cellular heterogeneity. From a metabolic perspective, glioma cancer cells can be classified into the oxidative metabolic phenotype (mainly depending on mitochondrial respiration for energy production) and glycolytic phenotype or "Warburg effect" (mainly depending on glycolysis). Herein, we reviewed the function of novel bio-active molecules targeting oxidative phosphorylation (OXPHOS), mitochondrial membrane potential and mitochondrial dynamics. These molecules exhibit intriguing preclinical and clinical results and have been proven to be promising candidates to be further developed for glioma therapy. However, despite these initial encouraging results, it is imperative to rigorously assess the side effects of these metabolic drugs, which have a non-negligible toxicity profile.
Insights
Novel drugs targeting cancer cell energy metabolism show promise for treating difficult glioma tumors. Further research is needed to balance their effectiveness against potential side effects and toxicity.
Area of Science:
- Biochemistry
- Oncology
- Mitochondrial Biology
Background:
- Glioma treatment presents significant challenges due to tumor complexity and cellular heterogeneity.
- Glioma cells exhibit diverse metabolic phenotypes, including oxidative phosphorylation and the Warburg effect.
- Targeting cancer cell metabolism is a promising therapeutic strategy.
Purpose of the Study:
- To review novel bioactive molecules targeting mitochondrial energy metabolism in glioma.
- To assess the potential of these molecules in preclinical and clinical settings for glioma therapy.
Main Methods:
- Literature review of studies on drugs targeting oxidative phosphorylation (OXPHOS), mitochondrial membrane potential, and mitochondrial dynamics.
- Analysis of preclinical and clinical data for efficacy and safety.
Main Results:
- Several novel molecules targeting mitochondrial functions show promising results in glioma treatment.
- These agents impact key aspects of cancer cell energy production.
Conclusions:
- Targeting mitochondrial metabolism represents a promising avenue for novel glioma therapies.
- Rigorous assessment of the toxicity and side effects of these metabolic drugs is crucial for clinical development.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...